For regular researcher list with their strategic groups, please click here.

Strategic Group 1:
Chronic Disease Management and End of Life Care

Leader : Christine Maheu

Strategic objectives:

  1. To develop interventions and health promotion measures to increase people's empowerment regarding their health;
  2. To develop interventions concerning the management of chronic diseases with the aim of reducing their impact on day-to-day functioning, as well as promoting the well-being and quality of life of people in precarious and complex health situations.

Through its projects, the RS1 aims to redefine the system to address health promotion issues and long-term care needs of people living with chronic diseases and their families. This research often involves the use of innovative technologies such as eHealth. Many of our researchers are evaluating innovative Web interventions in their projects, offering great opportunities to improve self-management and quality of care for people living with chronic diseases and their families.

Strategic Group 2:
Accessibility, Continuity and Safety in Care

Leader : Geneviève Roch

Strategic objectives:

  1. To improve the provision of nursing care across different continuums of health services, including intra and interprofessional practices, and by building on an innovative and efficient organizational culture;
  2. To facilitate the safe transition of people and improve the continuity of care and services;
  3. To promote nursing workforce mobilization by maximizing the scope of practice and roles, as well as quality of life at work, and by creating healthy and safe environments in contexts of change.

Several RS2 projects focus on the development of the nursing in different continuums of services, the evaluation of innovations aimed at creating healthy, mobilizing and safe environments, as well as the cost, organizational and clinical analysis of nursing interventions.

Strategic Group 3:
Care of populations in vulnerable situations

Leader : Marilyn Aita

Strategic objectives:

  1. To improve the assessment, prevention and management of symptoms in vulnerable populations and in different settings of care;
  2. To provide personalized care that maximizes the health, well-being and quality of life of vulnerable populations.

RS3 projects that reach vulnerable populations (children in critical health conditions, the elderly, people with intellectual disabilities, etc.) in complex clinical situations evaluate many technological innovations, which contributes to the advancement of knowledge with regard to symptom assessment and management, as well as the development and evaluation of personalized health care interventions.